Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,239
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,844
Class I recallsReasonable probability of serious health consequences
24,383
Class II recallsTemporary or medically reversible health consequences
2,897
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,084 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/eden-brothers-recalls-calabrese-broccoli-seeds-due-possible-salmonella-contaminationPublished October 7, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,383
Class I9,844
Class III2,897
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,383
Class I9,844
Class III2,897
Not Yet Classified2

Showing 19,701–19,720 of 20,461 recalls

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Testosterone Cypionate 200 mg/mL Injectable, 10 mL vials, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

MIC (Methionine, Inositol, and Choline) + B12 25/50/50mg/1000mcg/mL Injectable, 30 mL vials, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Phosphatidyl Choline 10%, Injectable, 500 mL vial, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

B-Complex 100 mg/mL Injectable, 50 mL vials, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Ascorbic Acid 500 mg/mL Injectable, 100 mL and 500 mL vials, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Procaine 1% Injectable, 100 mL and 250 mL vials, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Methylcobalamin 1,000 mcg/mL Injectable, 50 mL vials, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Mitomycin 0.3 mg/mL Injectable, 10 mL vials, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Lipoic Acid 25 mg/mL Injectable, 100 mL vials, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Glutathione 200 mg/mL Injectable, 50 mL vials, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Sodium EDTA 150 mg/mL Injectable, 250 mL vial, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Hydroxyprogesterone 250 mg/mL Injectable, 4 mL, 6 mL,8 mL and 10 mL vials, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Dexamethasone 10 mg/mL Injectable, 2 mL vial, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Dexpanthenol 200 mg/mL Injectable, 100 mL vial, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Betamethasone 6 mg/mL Injectable, 5 mL vial, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Baclofen/Bupivacaine 2,000 mcg/20 mg/mL Injectable, 45 mL vial, Compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Baclofen 1,000 mcg/mL Injectable, 20 mL and 40 mL vial, Compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Baclofen 500 mcg/mL Injectable, 22 mL vial, Compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Avastin 1.25 mg/0.05 mL Injectable, 4 mL vials, Compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Methotrexate 25mg/mL Injectable, 10 mL vials, Compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.